This training program provides 8 - 12 weeks of basic and outcomes research training for medical students aspiring to careers as clinician-scientists with a budding interest in vascular surgery. Mentored research training in molecular and cell biology, biomechanics, coagulation thrombosis, angiogenesis and clinical outcomes is provided with a focus on clinically relevant problems such as atherogenesis, intimal hyperplasia, prosthetic/host interactions and thrombosis. This program will replace our privately funded and highly successful, The William J. von Liebig Summer Research Program in Vascular Surgery, now drawing to a close. Students pursue a program of highly mentored research, conducted and closely supervised by the program director, co-director and mentors who have well-established records of peer-reviewed research, and who were selected both for the current research activities and their proven commitment to train medical student research fellows. Students are matched with the program's faculty on the basis of the background and research interest of the individual student. Students are provided with a specific, achievable goal within an ongoing research project. They work directly with a postdoctoral fellow who supervises daily activities and who has a specific assignment of mentorship. Students also have a protected time on a weekly basis with the senior investigators/mentors. Programs in responsible conduct of research along with classroom-based discussion section is mandatory. In addition to didactic lectures presented by the faculty, at weekly meetings of all students, an established mentor provides an overview of his/her career and laboratory history. The mentors and postdoctoral fellows are part of our parallel and highly successful T32: Harvard-Longwood Research Training in Vascular Surgery. This program has a focus on research related to vascular surgery and gives students a further perspective on the evolution of an academic career. It also demonstrates the value of interdisciplinary collaboration through our exemplary faculty. Upon completion of the T35 program, the student will have had an introductory research experience in the most positive light. They will have come to know successful Clinician-Scientists and will be supported as much as possible as their career evolves regardless of their final chosen specialty. All students have access to Harvard libraries, and the opportunity to attend myriad didactic sessions in the Longwood Medical area. Selection is based on the candidates' demonstrated ability and interest in an academic career. Applicants will be students who have completed at least one year of medical school. Our applicant pool is drawn from a national search, which consistently (under the preexisting program) brings us about 40 highly qualified applicants. Special attention is given to recruitment of women and minorities. We attract outstanding students from all over the country and have demonstrated our commitment to providing an inspiring experience that will foster interest in a clinician-scientist career.

Public Health Relevance

Vascular Surgeons provide a practical 'hands on' perspective on the relevant problems of devices and interventions on blood vessels. This program aspires to create a cadre of physician scientists who can develop expertise in research fundamentals essential to frontline 'bench to bedside to public policy' programs in treatment of vascular disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
NRSA Short -Term Research Training (T35)
Project #
5T35HL110843-03
Application #
8894071
Study Section
Special Emphasis Panel (ZHL1)
Program Officer
Meadows, Tawanna
Project Start
2013-08-01
Project End
2016-07-31
Budget Start
2015-08-01
Budget End
2016-07-31
Support Year
3
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
Dao, Duy T; Nandivada, Prathima; Vuong, Jacqueline T et al. (2018) Vascular endothelial growth factor accelerates compensatory lung growth by increasing the alveolar units. Pediatr Res 83:1182-1189
Dao, Duy T; Vuong, Jacqueline T; Anez-Bustillos, Lorenzo et al. (2018) Intranasal delivery of VEGF enhances compensatory lung growth in mice. PLoS One 13:e0198700
Fell, Gillian L; Cho, Bennet S; Pan, Amy et al. (2017) A Comparison of Fish Oil Sources for Parenteral Lipid Emulsions in a Murine Model. JPEN J Parenter Enteral Nutr 41:181-187
Chen, Jiaxuan; Howell, Caitlin; Haller, Carolyn A et al. (2017) An immobilized liquid interface prevents device associated bacterial infection in vivo. Biomaterials 113:80-92
Bodewes, Thomas C F; Johnson, Joel M; Auster, Michael et al. (2017) Intraluminal delivery of thrombospondin-2 small interfering RNA inhibits the vascular response to injury in a rat carotid balloon angioplasty model. FASEB J 31:109-119
Moll, Herwig P; Lee, Andy; Peterson, Clayton R et al. (2016) A20 Haploinsufficiency Aggravates Transplant Arteriosclerosis in Mouse Vascular Allografts: Implications for Clinical Transplantation. Transplantation 100:e106-e116
Sharma, Gaurav; Kulkarni, Rohan; Shah, Samir K et al. (2016) Local perivascular adiponectin associates with lower extremity vascular operative wound complications. Surgery 160:204-210
Sharma, Gaurav; Tao, Ming; Ding, Kui et al. (2015) Perivascular adipose adiponectin correlates with symptom status of patients undergoing carotid endarterectomy. Stroke 46:1696-9